Latest news and articles about wegovy from NEX English
Novo Nordisk has achieved the best obesity drug launch this year with its medication Wegovy, surpassing 600,000 prescriptions. This move comes as Eli Lilly intensifies competition by introducing new pills to attract patients.
Novo Nordisk announced a rise in its shares by up to 4% following a recommendation from the National Institute for Health and Care Excellence (NICE) in England to use Wegovy as a treatment for preventing heart attacks and strokes. This decision significantly expands patient access to this effective treatment within the English healthcare system.